The description of intracytoplasmic inclusion bodies in 1911 established the medical foundation for the condition now identified as Lafora disease. Gonzalo Rodríguez Lafora, a central figure in the Spanish Neurological School, maintained a career spanning psychiatry, neuropathology, and neurology. His contributions emerged from Madrid, where he trained under Santiago Ramón y Cajal and Nicolás Achúcarro during the twentieth century.
Professional Origins and The Cajal School
Lafora developed his clinical expertise as a disciple of Santiago Ramón y Cajal and Nicolás Achúcarro. This intellectual lineage placed him at the heart of the Spanish Neurological School. Working during a period when laboratory medicine and public health standards were fundamentally reshaping medical practice, he conducted research that bridged the gaps between psychiatry and the structural study of the brain.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Contributions to Pathology
His primary achievement involved the classification of microscopic structures within cellular cytoplasm. In 1911, he collaborated with B. Glueck to publish findings on the histopathology of myoclonic epilepsy, which led to the recognition of what is now titled Lafora disease. His scholarly output was prolific, resulting in approximately 200 papers throughout his life that addressed complex issues across the fields of neurology, psychiatry, and neuropathology.
The Eponym Debate
Historical analysis of neurodegenerative research reveals a significant naming dispute involving Lafora. In 1910, Fritz Heinrich Lewy identified structures now known as Lewy bodies. Lafora reported similar findings in 1913, acknowledging Lewy's prior discovery by naming them cuerpos intracelulares de Lewy. While Konstantin Nikolaevich Trétiakoff received credit for these findings in 1919 after identifying them in the substantia nigra, recent scholarship from 2017 by Eliasz Engelhardt suggests that Lafora's prior use of the term warrants a historical reassessment of the eponym.
Legacy and Institutional Role
Beyond his clinical research, Lafora served as a member of the Royal National Academy of Medicine. He dedicated significant effort to the training of new practitioners, fostering a group of disciples who maintained his emphasis on scientific rigour. His work took place within the specific institutional and economic environment of Spain, influencing the development of neuroscientific research in the country until his death in 1971 at the age of 85.
Fast facts
- Born: 1886, Madrid
- Died: 1971, Madrid
- Fields: Neurology, psychiatry, neuropathology
- Membership: Royal National Academy of Medicine
- Major research: Lafora disease
- Published papers: Approximately 200
- Mentors: Santiago Ramón y Cajal, Nicolás Achúcarro
Questions readers ask
What is Lafora disease?
It is a rare condition marked by the presence of intracytoplasmic inclusion bodies, first described by Gonzalo Rodríguez Lafora in 1911.
Was Lafora involved in the naming of Lewy bodies?
Yes, he described these structures in 1913 and explicitly named them 'cuerpos intracelulares de Lewy' to credit Fritz Heinrich Lewy, though modern debates exist regarding the attribution of the name.
Achievements
- Fields: neurology, neuropathology and psychiatry
.jpg)